A fluorescence-based sequence-specific primer PCR for the screening of HLA-B(*)57:01.

Abstract	Abacavir (ABC) is an antiretroviral drug highly effective in the treatment of HIV, but its intake can cause severe hypersensitivity reaction (HSR). A strong association between HLA-B()57:01 and ABC HSRs was reported by several studies, which demonstrated that HLA-B()57:01 screening had a 100% negative predictive value and that it could accurately identify patients at high risk of ABC HSRs. We propose a new sequence-specific primer PCR assay based on fluorescence detection through CE which is highly sensitive, allowing the use of non-infective sources of DNA such as saliva and buccal swabs, in addition to blood and reproducible, allowing automation of the analytical process. The results of our study were first compared with a standard sequence-specific primer PCR technique and reported a concordance of 100%, and then a blind external validation further confirmed the accuracy of our method.
Authors	Emiliano Giardina, Laura Stocchi, Valeria Foti Cuzzola, Stefania Zampatti, Stefano Gambardella, Maria Patrizia Patrizi, Placido Bramanti, Antonella Pirazzoli, Giuseppe Novelli
Journal	Electrophoresis (Electrophoresis) Vol. 31 Issue 21 Pg. 3525-30 (Oct 2010) ISSN: 1522-2683 [Electronic] Germany
PMID	20925049 (Publication Type: Journal Article)
Chemical References	DNA Primers Dideoxynucleosides HLA-B Antigens HLA-B*57:01 antigen DNA abacavir
Topics	Blood Chemical Analysis Cheek DNA (chemistry, isolation & purification) DNA Primers Dideoxynucleosides (adverse effects, therapeutic use) Drug Hypersensitivity (genetics, immunology, prevention & control) Electrophoresis, Capillary (methods) Genetic Predisposition to Disease Genetic Testing (methods) HIV Infections (drug therapy, genetics, immunology) HLA-B Antigens (genetics) Humans Mouth Mucosa (chemistry) Polymerase Chain Reaction (methods) Reproducibility of Results Sensitivity and Specificity Spectrometry, Fluorescence (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!